D.E. Shaw & Co’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Sell
579,296
-90,992
-14% -$4.9M 0.03% 892
2025
Q4
$32.5M Buy
670,288
+320,928
+92% +$12.5M 0.02% 950
2025
Q3
$10.7M Buy
349,360
+237,011
+211% +$5.44M 0.01% 1621
2025
Q2
$2.49M Sell
112,349
-17,305
-13% -$362K ﹤0.01% 2578
2025
Q1
$2.41M Sell
129,654
-67,453
-34% -$1.13M ﹤0.01% 2470
2024
Q4
$2.61M Sell
197,107
-27,030
-12% -$655K ﹤0.01% 2519
2024
Q3
$7.51M Buy
224,137
+52,687
+31% +$1.8M 0.01% 1627
2024
Q2
$4.3M Sell
171,450
-15,354
-8% -$358K 0.01% 1971
2024
Q1
$4.21M Buy
186,804
+26,478
+17% +$627K 0.01% 2021
2023
Q4
$3.43M Buy
160,326
+14,434
+10% +$249K 0.01% 2234
2023
Q3
$2.62M Sell
145,892
-59,904
-29% -$1.14M ﹤0.01% 2364
2023
Q2
$4.19M Sell
205,796
-1,256
-0.6% -$25.5K 0.01% 2005
2023
Q1
$4.51M Buy
207,052
+32,854
+19% +$798K 0.01% 2027
2022
Q4
$5.4M Sell
174,198
-2,302
-1% -$65K 0.01% 2024
2022
Q3
$4.5M Buy
176,500
+45,348
+35% +$1.06M 0.01% 2218
2022
Q2
$2.66M Sell
131,152
-38,408
-23% -$851K ﹤0.01% 2815
2022
Q1
$4.2M Sell
169,560
-43,121
-20% -$1.31M 0.01% 2523
2021
Q4
$7.39M Sell
212,681
-41,111
-16% -$1.3M 0.01% 1973
2021
Q3
$6.88M Sell
253,792
-4,852
-2% -$123K 0.01% 1828
2021
Q2
$6.71M Sell
258,644
-36,950
-13% -$886K 0.01% 1804
2021
Q1
$6.37M Sell
295,594
-269,331
-48% -$6.8M 0.01% 1680
2020
Q4
$12.1M Sell
564,925
-76,021
-12% -$1.85M 0.01% 1263
2020
Q3
$9.45M Sell
640,946
-58,821
-8% -$1.06M 0.01% 1279
2020
Q2
$15.6M Buy
699,767
+241,706
+53% +$4.42M 0.02% 908
2020
Q1
$6.47M Buy
458,061
+92,670
+25% +$1.41M 0.01% 1273
2019
Q4
$5.94M Buy
+365,391
New +$8.64M 0.01% 1596
2018
Q2
Sell
-39,616
Closed -$4.12M 3677
2018
Q1
$4.12M Buy
39,616
+34,488
+673% +$3.89M 0.01% 1533
2017
Q4
$516K Sell
5,128
-7,754
-60% -$571K ﹤0.01% 2965
2017
Q3
$450K Buy
+12,882
New +$347K ﹤0.01% 2964

Other funds holding ANAB